Tevogen Bio Holdings Inc. (TVGNW)
TVGNW Stock Price Chart
Explore Tevogen Bio Holdings Inc. interactive price chart. Choose custom timeframes to analyze TVGNW price movements and trends.
TVGNW Company Profile
Discover essential business fundamentals and corporate details for Tevogen Bio Holdings Inc. (TVGNW) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
—
Employees
18.00
Website
https://tevogen.comCEO
Ryan H. Saadi M.P.H,
Description
Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.
TVGNW Financial Timeline
Browse a chronological timeline of Tevogen Bio Holdings Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 14 Aug 2025
EPS came in at -$0.03 surpassing the estimated -$0.03 by +0.47%.
Earnings released on 14 May 2025
EPS came in at -$0.06 falling short of the estimated -$0.05 by -31.89%.
TVGNW Stock Performance
Access detailed TVGNW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.